Medicare Enrolled

Stacy Creel

Acute Care Nurse Practitioner · Savannah, GA
6602 WATERS AVE BLDG C, Savannah, GA 31406
9123547676
Registered in NPPES since 2015
NPI: 1679956056 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Creel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Creel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Creel

Stacy Creel is an acute care nurse practitioner in Savannah, GA, with 11 years of NPI registration.

Between the years covered by Open Payments, Creel received a total of $12,350 from 62 pharmaceutical and/or device companies across 619 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Creel is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration $12,350 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,350
Total received (2021-2024)
Avg $3,087/year across 4 years
Top 0% in GA for acute care nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
619
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,854
2023
$3,257
2022
$2,687
2021
$1,551

Payments by company (2024)

LivaNova USA, Inc.
$1,800
ABBVIE INC.
$453
Biogen, Inc.
$314
UCB, Inc.
$295
Novartis Pharmaceuticals Corporation
$165
Mallinckrodt Hospital Products Inc.
$148
EMD Serono, Inc.
$140
Alexion Pharmaceuticals, Inc.
$114
SCILEX PHARMACEUTICALS INC.
$109
Teva Pharmaceuticals USA, Inc.
$104
Ipsen Biopharmaceuticals, Inc
$101
Neurocrine Biosciences, Inc.
$98
PFIZER INC.
$91
Lundbeck LLC
$90
SK Life Science, Inc.
$80
Neurelis, Inc.
$79
JAZZ PHARMACEUTICALS INC.
$79
CATALYST PHARMACEUTICALS, INC.
$71
Celgene Corporation
$55
ARGENX US, INC.
$52
Lilly USA, LLC
$50
ACADIA Pharmaceuticals Inc
$46
Amgen Inc.
$45
Averitas Pharma Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
TG Therapeutics, Inc.
$36
Genentech USA, Inc.
$35
Sumitomo Pharma America, Inc.
$35
Boston Scientific Corporation
$25
Otsuka America Pharmaceutical, Inc.
$21
AstraZeneca Pharmaceuticals LP
$17
Eisai Inc.
$17
InSightec,Inc
$14
Top 3 companies account for 52.9% of 2024 payments
All-time payments by company (2021-2024) ›
LivaNova USA, Inc.
$1,825
ABBVIE INC.
$1,282
UCB, Inc.
$746
Novartis Pharmaceuticals Corporation
$668
EMD Serono, Inc.
$602
Biogen, Inc.
$589
Teva Pharmaceuticals USA, Inc.
$392
SK Life Science, Inc.
$391
Neurelis, Inc.
$372
Ipsen Biopharmaceuticals, Inc
$367
Mallinckrodt Hospital Products Inc.
$345
ARGENX US, INC.
$330
AbbVie Inc.
$297
Alexion Pharmaceuticals, Inc.
$280
Neurocrine Biosciences, Inc.
$265
JAZZ PHARMACEUTICALS INC.
$236
Lundbeck LLC
$229
PFIZER INC.
$216
Sunovion Pharmaceuticals Inc.
$190
Boston Scientific Corporation
$144
Genentech USA, Inc.
$144
Merz Pharmaceuticals, LLC
$141
Amgen Inc.
$133
Celgene Corporation
$111
SCILEX PHARMACEUTICALS INC.
$109
Sumitomo Pharma America, Inc.
$107
Janssen Pharmaceuticals, Inc
$102
ACADIA Pharmaceuticals Inc
$99
EISAI INC.
$94
Otsuka America Pharmaceutical, Inc.
$92
Scilex Pharmaceuticals Inc.
$89
Harmony Biosciences LLC
$86
CSL Behring
$85
Eisai Inc.
$85
Kyowa Kirin, Inc.
$75
CATALYST PHARMACEUTICALS, INC.
$71
Biohaven Pharmaceutical Holding Company Ltd.
$71
Horizon Therapeutics plc
$70
Catalyst Pharmaceuticals, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$64
Allergan, Inc.
$61
MITSUBISHI TANABE PHARMA AMERICA, INC.
$60
Acorda Therapeutics, Inc
$57
AQUESTIVE THERAPEUTICS, INC.
$57
Lilly USA, LLC
$50
Sarepta Therapeutics, Inc.
$39
Adamas Pharmaceuticals, Inc.
$39
Averitas Pharma Inc.
$38
TG Therapeutics, Inc.
$36
IMPEL PHARMACEUTICALS INC.
$30
Alnylam Pharmaceuticals Inc.
$26
Biohaven Pharmaceuticals, Inc.
$25
Grifols USA, LLC
$24
HOSPIRA, INC.
$22
AstraZeneca Pharmaceuticals LP
$17
SANOFI-AVENTIS U.S. LLC
$17
BOSTON SCIENTIFIC CORPORATION
$16
GENZYME CORPORATION
$15
Corium, LLC
$15
HARMONY BIOSCIENCES LLC
$14
InSightec,Inc
$14
Medtronic, Inc.
$12
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Azstarys · BOTOX · BRIUMVI · Briviact · DAYBUE · DUOPA · DYSPORT · Dysport · ELYXYB - CELECOXIB · EPIDIOLEX · Enspryng · Exablate · Exondys 51 · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LINQ II · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · Radicava · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Wakix · WaveWriter Alpha Prime 16 · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an acute care nurse practitioner in Savannah?
Compare acute care nurse practitioners in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse acute care nurse practitioners nearby

Geographic Context

Acute care nurse practitioners in nearby ZIP areas
20
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
COASTAL HARBOR TREATMENT CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Creel is an acute care nurse practitioner.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Creel receive payments from pharmaceutical companies?
Yes. Creel received a total of $12,350 from 62 companies across 619 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Creel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →